Related Experiment Video

Updated: May 15, 2026

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues
11:54

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Published on: October 20, 2019

Cardiac hydatid disease: literature review

Vijayakumar Abhishek1, Vijayakumar Avinash

  • 1Department of General Surgery, Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, India. abhishekbmc@yahoo.co.in

Asian Cardiovascular & Thoracic Annals
|January 4, 2013
PubMed

Insights

Hydatid disease, a parasitic infection, rarely affects the heart but can be fatal. Early diagnosis and surgical removal are crucial for managing this rare cardiac condition.

Area of Science:

  • Parasitology
  • Cardiology
  • Infectious Diseases

Background:

  • Hydatid disease is a global parasitic infection with a low incidence.
  • Cardiac involvement is exceptionally rare, seen in 0.02%-2% of cases.
  • Often asymptomatic, cardiac hydatid disease can lead to severe complications and high mortality.

Purpose of the Study:

  • To review the diverse clinical presentations of cardiac hydatid disease.
  • To highlight methods for early diagnosis of this rare condition.
  • To discuss current management strategies, focusing on surgical excision.

Main Methods:

  • Literature review of case reports and studies on cardiac hydatid disease.
  • Analysis of diagnostic modalities and treatment outcomes.
  • Synthesis of information on epidemiology and clinical manifestations.

Main Results:

  • Cardiac hydatid disease presents with varied symptoms, often mimicking other cardiac pathologies.
  • Early diagnosis is challenging due to rarity and asymptomatic nature.
  • Surgical excision remains the primary treatment modality.

Conclusions:

  • Prompt recognition and diagnosis are vital for improving patient outcomes.
  • Surgical intervention is essential for effective management of cardiac hydatid disease.
  • Further research is needed to refine diagnostic and therapeutic approaches.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...